An insulin pump maker is recalling certain pods that can fail to fully infuse insulin in the body. The recall comes after 18 reports of “serious adverse events." ...

An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. State-level out-of-pocket insulin caps did not boost ...

A new survey, published in The Joint Commission Journal on Quality and Patient Safety, examined insulin pen use in the inpatient setting. Insulin pens can offer several advantages, but there have also ...

To characterize glucose levels and insulin use daily and during hospital shifts throughout hospitalization, which might inform treatment planning and improve outcomes. This is a post hoc analysis from ...

Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...

In this clip, Elise S. Tremblay, MD, MPH, explores factors behind fluctuations in insulin out-of-pocket costs and highlights the serious health consequences of persistently lower insulin use. She ...

Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

While out-of-pocket caps on insulin indeed cut down on costs for commercially insured patients in the U.S., the policies didn't do much to increase insulin use, claims data showed. After such policies ...

Omnipod 5 is the first AID system cleared for type 1 and type 2 diabetes management. Insulet’s Omnipod ® 5 Automated Insulin Delivery (AID) System has been cleared by the Food and Drug Administration ...

A flavorful way to manage your insulin resistance!